Sun Pharma receives DCGI approval to manufacture and market generic semaglutide injection in India for chronic weight management Read more
Biocon signs licensing and supply pact with Biomm S.A for Semaglutide commercialisation in Brazil Read more
Novo Nordisk Wegovy’s NHS access marks milestone in obesity treatment, but challenges remain: GlobalData Read more
With oral Semaglutide, HCPs can provide robust HbA1c control to their type-II diabetes patients Read more